MDT

100.71

0%↓

135.72

-0.01%↓

VEEV

217.61

-2.73%↓

HQY

82.76

-2.65%↓

NEOG

10.24

+2.4%↑

MDT

100.71

0%↓

135.72

-0.01%↓

VEEV

217.61

-2.73%↓

HQY

82.76

-2.65%↓

NEOG

10.24

+2.4%↑

MDT

100.71

0%↓

135.72

-0.01%↓

VEEV

217.61

-2.73%↓

HQY

82.76

-2.65%↓

NEOG

10.24

+2.4%↑

MDT

100.71

0%↓

135.72

-0.01%↓

VEEV

217.61

-2.73%↓

HQY

82.76

-2.65%↓

NEOG

10.24

+2.4%↑

MDT

100.71

0%↓

135.72

-0.01%↓

VEEV

217.61

-2.73%↓

HQY

82.76

-2.65%↓

NEOG

10.24

+2.4%↑

Kodu・Aktsiate loetelu・Talphera Inc.

Talphera Inc.

Avatud

0.99

Osta Müü

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

0.97

Max

Põhinäitajad
By Trading Economics
Töötajad	13

Soovitused
By TipRanks
Soovitused	Osta
12 kuu keskmine prognoos	+225% upside

Dividendid
By Dow Jones
Järgmine tulemuste avaldamine	30. märts 2026

Turustatistika
By TradingEconomics
Turukapital	-22M 39M
Eelmine avamishind	0.99
Eelmine sulgemishind	0.99

Talphera Inc. Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

26. jaan 2026, 23:49 UTC

Kuumad aktsiad

Stocks to Watch: Agilysys, Nucor, Humana, UnitedHealth

26. jaan 2026, 23:09 UTC

Suurimad hinnamuutused turgudel

Health Insurers' Shares Fall After Government Proposes Flat Medicare Advantage Rate

26. jaan 2026, 23:52 UTC

Market Talk

Gold's Path of Least Resistance Still Looks Higher, Technical Analysis Shows -- Market Talk

26. jaan 2026, 23:46 UTC

Market Talk

Nikkei May Decline as Yen's Rebound Raises Caution Over Earnings -- Market Talk

26. jaan 2026, 23:37 UTC

Market Talk

Gold Rises Amid Concerns Over Tariffs -- Market Talk

26. jaan 2026, 22:41 UTC

Market Talk

Australian 4Q CPI To Provide Smoking Gun For Hike -- Market Talk

26. jaan 2026, 22:26 UTC

Tulu

Karoon Expects Capex of US$110 Million-US$135 Million in 2026

26. jaan 2026, 22:26 UTC

Tulu

Karoon Expects Operating Costs to Fall Once Transition of Bauna FPSO Operatorship Completes

26. jaan 2026, 22:25 UTC

Tulu

Karoon Energy Expects Unit Production Cost of US$12-US$15/BOE in 2026

26. jaan 2026, 22:25 UTC

Tulu

Karoon Energy Expects Output to Rise in 2H Following Bauna Investment Program

26. jaan 2026, 22:25 UTC

Tulu

Karoon Energy Expects Output of 8.1 Million-9.2 Million BOE in 2026

26. jaan 2026, 22:24 UTC

Tulu

Karoon Energy 4Q Sales Revenue US$156.1 Million

26. jaan 2026, 22:23 UTC

Tulu

Karoon Energy 4Q Sales Volumes 2.65 Million BOE, Up 5% on Quarter

26. jaan 2026, 22:23 UTC

Tulu

Karoon Energy: Bauna FPSO Efficiency Increased to 98.8%

26. jaan 2026, 22:23 UTC

Tulu

Karoon Energy FY Oil, Natural Gas Production 10.3 Million BOE

26. jaan 2026, 22:22 UTC

Tulu

Karoon Energy 4Q Oil, Natural Gas Production 2.37 Million BOE

26. jaan 2026, 22:05 UTC

Omandamised, ülevõtmised, äriostud

Fortescue: Alta Copper Shareholders Approve Takeover

26. jaan 2026, 22:02 UTC

Omandamised, ülevõtmised, äriostud

Senate Antitrust Panel Chair Raises Concerns Over Netflix-Warner Deal -- WSJ

26. jaan 2026, 21:50 UTC

Market Talk

Tulu

Financial Services Roundup: Market Talk

26. jaan 2026, 21:50 UTC

Market Talk

Auto & Transport Roundup: Market Talk

26. jaan 2026, 21:34 UTC

Tulu

Nucor: Steel Products Segment Expected Improved Earnings in 1Q Due to Increased Volumes on Stable Pricing >NUE

26. jaan 2026, 21:34 UTC

Tulu

Nucor: Steel Mills Segment Expected Increase Is Due to Higher Volumes and Higher Realized Prices Across All Major Pdt Categories >NUE

26. jaan 2026, 21:34 UTC

Tulu

Nucor: Raw Materials Segment Is Expected to Have Increased Earnings in 1Q >NUE

26. jaan 2026, 21:34 UTC

Tulu

Nucor: 1Q Earnings Expected to Increase Across All Three Operating Segments, With the Largest Increase in Steel Mills Segment >NUE

26. jaan 2026, 21:30 UTC

Omandamised, ülevõtmised, äriostud

Eaton Stock Rises on Spin-Off Plan. Why It's Going All-In on Planes and AI Data Centers. -- Barrons.com

26. jaan 2026, 21:30 UTC

Tulu

Nucor 4Q Sales $7.69B >NUE

26. jaan 2026, 21:30 UTC

Tulu

Nucor 4Q Net $378M >NUE

26. jaan 2026, 21:30 UTC

Tulu

Nucor 4Q Steel Mills Total Shipments 5.91M Tons >NUE

26. jaan 2026, 21:30 UTC

Tulu

Nucor 4Q Total Tons Shipped to Outside Customers Down 9% >NUE

26. jaan 2026, 21:30 UTC

Tulu

Nucor 4Q EPS $1.64 >NUE

Võrdlus sarnastega

Hinnamuutus

Talphera Inc. Prognoos

Hinnasiht

By TipRanks

225% tõus

12 kuu keskmine prognoos

Keskmine 3.25 USD 225%

Kõrge 3.5 USD

Madal 3 USD

Põhineb 2 Wall Streeti analüütiku instrumendi Talphera Inc. 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Osta

2 ratings

Osta

Hoia

Müü

Põhineb 2 analüütiku instrumendi Talphera Inc. aktsia reitingul - viimase 3 kuu andmed.

Finantsandmed

Ettevõttest Talphera Inc.

Talphera, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for use in medically supervised settings. Its lead product candidate is Niyad, a lyophilized formulation of nafamostat, which is under an investigational device exemption as an anticoagulant for the extracorporeal circuit. It is also developing LTX-608, an anti-inflammatory and antiviral potential for the treatment of multiple conditions, including disseminated intravascular coagulation (DIC), acute respiratory distress syndrome (ARDS), and acute pancreatitis; Fedsyra, a pre-filled ephedrine syringe; and PFS-02, a pre-filled phenylephrine syringe. The company was formerly known as AcelRx Pharmaceuticals, Inc. and changed its name to Talphera, Inc. in January 2024. The company was incorporated in 2005 and is headquartered in San Mateo, California.